本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

20.08
-0.0800-0.40%
成交量:85.13万
成交额:1,687.92万
市值:25.67亿
市盈率:116.47
高:20.32
开:20.32
低:19.55
收:20.16
52周最高:30.48
52周最低:16.10
股本:1.28亿
流通股本:7,811.99万
量比:0.55
换手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
净资产收益率:7.48%
总资产收益率:3.53%
市净率:6.93
市盈率(LYR):116.47

数据加载中...

2021/02/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/26

重要事件披露

8-K - Current report
2021/01/07

重要事件披露

8-K - Current report
2021/01/04

重要事件披露

8-K - Current report
2020/11/02

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/27

重要事件披露

8-K - Current report
2020/07/30

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/06/01

重要事件披露

8-K - Current report
2020/05/13

重要事件披露

8-K - Current report
2020/05/07

重要事件披露

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
2020/04/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/06

重要事件披露

Current report, item 5.02
2020/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans